| |
| |
|
| Insider
Information: |
Scodari Joseph C |
| Relationship: |
Director |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,468 |
|
|
Indirect Shares
|
2,845 |
|
|
| Direct
Value |
$2,762,630 |
|
|
|
Indirect Value
|
$416,565 |
|
|
| Total
Shares |
62,313 |
|
|
| Total
Value |
$3,179,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Johnson & Johnson |
JNJ |
Retired Exec Committee... |
2008-05-28 |
18,646 |
2008-04-30 |
2,845 |
Premium* |
|
|
Endo Health Solutions Inc |
ENDP |
Director |
2013-03-12 |
6,515 |
|
0 |
Premium* |
|
|
Covance Inc |
CVD |
Director |
2015-02-19 |
0 |
2008-08-12 |
0 |
Premium* |
|
|
Optinose Inc |
OPTN |
Director |
2021-05-10 |
31,230 |
2018-12-12 |
0 |
Premium* |
|
|
Acurx Pharmaceuticals, Inc. |
ACXP |
Director |
2021-06-24 |
3,077 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2008-08-04 |
4 |
B |
$23.02 |
$49,493 |
D/D |
2,150 |
4,268 |
2.39 |
- |
|
| JNJ |
Johnson & Johnson |
Retired Exec Committee Member |
– – – |
2008-05-28 |
4 |
OE |
$47.39 |
$3,496,956 |
D/D |
67,185 |
83,731 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
Executive Committee Member |
• – – |
2006-10-24 |
4 |
OE |
$50.69 |
$2,940,020 |
D/D |
58,000 |
64,928 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
– • – |
2010-05-20 |
4 |
D |
$51.69 |
$1,913 |
D/D |
(37) |
500 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
Executive Committee Member |
• – – |
2008-01-25 |
4 |
OE |
$52.20 |
$297,144 |
D/D |
5,465 |
14,110 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
– • – |
2010-06-17 |
4 |
B |
$54.55 |
$10,910 |
D/D |
200 |
700 |
2.39 |
- |
|
| CVD |
Covance Inc |
Director |
– • – |
2011-06-24 |
4 |
B |
$57.38 |
$45,904 |
D/D |
800 |
1,500 |
2.39 |
- |
|
| CVD |
Covance Inc |
Director |
– • – |
2011-05-20 |
4 |
D |
$60.98 |
$48,784 |
D/D |
(800) |
700 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
Retired Exec Committee Member |
– – – |
2008-05-28 |
4 |
S |
$64.73 |
$4,214,592 |
D/D |
(65,085) |
18,646 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
Executive Committee Member |
• – – |
2006-10-24 |
4 |
S |
$68.50 |
$3,975,041 |
D/D |
(58,000) |
6,928 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2013-05-20 |
4 |
D |
$75.96 |
$121,538 |
D/D |
(1,600) |
5,040 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2014-05-20 |
4 |
D |
$83.78 |
$126,083 |
D/D |
(1,505) |
7,466 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
– • – |
2008-08-12 |
4 |
B |
$97.29 |
$48,645 |
D/D |
500 |
500 |
2.39 |
- |
|
63 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
